comparemela.com

Latest Breaking News On - Selvita group - Page 1 : comparemela.com

Selvita completes acquisition of PozLab and significantly expands its drug development capabilities

KRAKÓW, Poland, May 7, 2024 /PRNewswire/ Selvita S.A. [WSE: SLV] announced today completion of a strategic transaction in which it has acquired 100% of shares in PozLab. The closing of the.

The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson s Disease

Selvita Q1 2023 financial results exceed initial estimates, the Company is preparing for further dynamic growth

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.